← Diphtheria

Patient counseling sheet

Print-ready and generated without storing patient details.

AfyaIndex · counseling handout

Diphtheria

Vaccine / immunological product

Prepared 20 Sep 2026

What it is used for

Therapeutic use is agent- and indication-specific within the class (Vaccine / immunological product). Use according to culture results, national guidelines (Kenya STG/EML where applicable) and the current product SmPC.

Warnings

[From component Diphtheria / Tetanus / Pertussis / Hepatitis B vaccine] Temperature of 400C within 48 hours, not due to another identifiable cause, collapse or shock-like state within 48 hours, persistent crying lasting 3 hours, occurring within 48 hours, convulsions with or without fever, occurring within 3 days.

Possible side effects

[From component Diphtheria / Tetanus / Pertussis / Hepatitis B vaccine] Pain, redness or swelling at injection site, fever (more than 38C), drowsiness, irritability, unusual crying, feeding problems.

Storage

Store as labelled. Keep out of reach of children.

No reviewed patient-education article is available. The fields shown are from the currently verified medicine record and unavailable fields are not inferred.

AfyaIndex dataset coverage